Revolutionising drug discovery with deep learning

Europe PMC and Open Targets develop Lit-OTAR framework unearthing over 48 million unique associations that can be leveraged for drug discovery Identifying drug targets is a critical and intricate part of drug discovery. This requires scientists to look at many sources of evidence. They use them to find links between drugs, targets, and diseases.